Cargando…
Cyclic GMP modulating drugs in cardiovascular diseases: mechanism-based network pharmacology
Mechanism-based therapy centred on the molecular understanding of disease-causing pathways in a given patient is still the exception rather than the rule in medicine, even in cardiology. However, recent successful drug developments centred around the second messenger cyclic guanosine-3′-5′-monophosp...
Autores principales: | Petraina, Alexandra, Nogales, Cristian, Krahn, Thomas, Mucke, Hermann, Lüscher, Thomas F, Fischmeister, Rodolphe, Kass, David A, Burnett, John C, Hobbs, Adrian J, Schmidt, Harald H H W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302891/ https://www.ncbi.nlm.nih.gov/pubmed/34270705 http://dx.doi.org/10.1093/cvr/cvab240 |
Ejemplares similares
-
It's cold, mom! It's cyclic GMP
por: Kuhn, Michaela
Publicado: (2015) -
Cyclic GMP and Cilia Motility
por: Wyatt, Todd A.
Publicado: (2015) -
Gating by Cyclic Gmp and Voltage in the α Subunit of the Cyclic Gmp–Gated Channel from Rod Photoreceptors
por: Benndorf, Klaus, et al.
Publicado: (1999) -
Adenine protonation enables cyclic-di-GMP binding to cyclic-GAMP sensing riboswitches
por: Keller, Heiko, et al.
Publicado: (2018) -
Ultrastructural localization of cyclic GMP and cyclic AMP in rat striatum
Publicado: (1981)